In the last 12 months, insiders at Damora Therapeutics, Inc. ($DMRA) filed 117 transactions with the SEC: 0 open-market purchases totaling $0 and 45 sales totaling $2,337,350. Net insider sentiment: net selling.
Damora Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- ORBIMED ADVISORS LLC (TenPercentOwner) — 36 transactions totaling $2,298,561
- Schambye Hans T. (Chief Executive Officer) — 13 transactions totaling $24,960
- Winslow Garrett (General Counsel) — 14 transactions totaling $8,971
- Firmani Lori (Chief Financial Officer) — 3 transactions totaling $2,890
- Firmani Lori (Interim CFO) — 8 transactions totaling $1,968
View all SEC Filings for Damora Therapeutics, Inc. (DMRA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Jarrett Jennifer | See Remarks | A | Stock Option (right to buy) | 1500000 | $0.00 | 1,500,000.0000 | 1,327,212 | 9999.99% | 100.00% |
| March 30, 2026 | Jarrett Jennifer | See Remarks | A | Common Stock | 500000 | $0.00 | 500,000.0000 | 1,327,212 | 9999.99% | 37.67% |
| March 23, 2026 | Winslow Garrett | General Counsel | A | Stock Option (right to buy) | 250000 | $0.00 | 250,000.0000 | 1,327,212 | 9999.99% | 18.84% |
| March 23, 2026 | Turtle Cameron | Not found | A | Stock Option (right to buy) | 37313 | $0.00 | 37,313.0000 | 1,327,212 | 9999.99% | 2.81% |
| March 23, 2026 | Landsittel Michael | Not found | A | Stock Option (right to buy) | 37313 | $0.00 | 37,313.0000 | 1,327,212 | 9999.99% | 2.81% |
| March 23, 2026 | CAIN CHRISTOPHER W. | Not found | A | Stock Option (right to buy) | 37313 | $0.00 | 37,313.0000 | 1,327,212 | 9999.99% | 2.81% |
| March 23, 2026 | Bruno Julianne | Not found | A | Stock Option (right to buy) | 37313 | $0.00 | 37,313.0000 | 1,327,212 | 9999.99% | 2.81% |
| March 23, 2026 | Fairmount Funds Management LLC | Not found | A | Stock Option (right to buy) | 37313 | $0.00 | 37,313.0000 | 1,327,212 | 9999.99% | 2.81% |
| Feb. 9, 2026 | Fairmount Funds Management LLC | Not found | M | Common Stock | 2904000 | $0.00 | 8,713,000.0000 | 1,327,212 | 49.99% | 100.00% |
| Feb. 9, 2026 | Fairmount Funds Management LLC | Not found | M | Series C Preferred Stock | 2904 | $0.00 | 1,722.0000 | 1,327,212 | 62.78% | 0.22% |
| Feb. 9, 2026 | Bruno Julianne | Not found | M | Common Stock | 129000 | $0.00 | 137,032.0000 | 1,327,212 | 1606.08% | 9.72% |
| Feb. 9, 2026 | Bruno Julianne | Not found | M | Series C Preferred Stock | 129 | $0.00 | 0.0000 | 1,327,212 | 100.00% | 0.01% |
| Feb. 9, 2026 | Fairmount Funds Management LLC | Not found | M | Common Stock | 5809000 | $0.00 | 8,713,000.0000 | 1,327,212 | 200.03% | 100.00% |
| Feb. 9, 2026 | Fairmount Funds Management LLC | Not found | M | Series C Preferred Stock | 5809 | $0.00 | 1,722.0000 | 1,327,212 | 77.13% | 0.44% |
| Jan. 5, 2026 | Sattarzadeh Sherwin | Chief Operating Officer | A | Common Stock | 190376 | $0.00 | 190,376.0000 | 1,327,212 | 9999.99% | 14.34% |
| Jan. 5, 2026 | Sattarzadeh Sherwin | Chief Operating Officer | A | Stock Option (right to buy) | 444209 | $0.00 | 444,209.0000 | 1,327,212 | 9999.99% | 33.47% |
| Jan. 5, 2026 | Hewes L. Becker | Chief Medical Officer | A | Common Stock | 264629 | $0.00 | 264,629.0000 | 1,327,212 | 9999.99% | 19.94% |
| Jan. 5, 2026 | Hewes L. Becker | Chief Medical Officer | A | Stock Option (right to buy) | 528603 | $0.00 | 528,603.0000 | 1,327,212 | 9999.99% | 39.83% |
| Jan. 2, 2026 | Winslow Garrett | General Counsel | M | Restricted Stock Units | 680 | $0.00 | 1,320.0000 | 1,327,212 | 34.00% | 0.05% |
| Jan. 2, 2026 | Winslow Garrett | General Counsel | M | Common Stock | 680 | $0.00 | 2,109.0000 | 1,327,212 | 47.59% | 0.05% |
| Jan. 2, 2026 | Schambye Hans T. | Chief Executive Officer | M | Restricted Stock Units | 1360 | $0.00 | 2,640.0000 | 1,327,212 | 34.00% | 0.10% |
| Jan. 2, 2026 | Schambye Hans T. | Chief Executive Officer | S | Common Stock | 700 | $21.38 | 4,682.0000 | 1,327,212 | 13.01% | 0.05% |
| Jan. 2, 2026 | Schambye Hans T. | Chief Executive Officer | M | Common Stock | 1360 | $0.00 | 5,382.0000 | 1,327,212 | 33.81% | 0.10% |
| Jan. 2, 2026 | Firmani Lori | Chief Financial Officer | M | Restricted Stock Units | 374 | $0.00 | 726.0000 | 1,327,212 | 34.00% | 0.03% |
| Jan. 2, 2026 | Firmani Lori | Chief Financial Officer | S | Common Stock | 135 | $21.41 | 931.0000 | 1,327,212 | 12.66% | 0.01% |
| Jan. 2, 2026 | Firmani Lori | Chief Financial Officer | M | Common Stock | 374 | $0.00 | 1,066.0000 | 1,327,212 | 54.05% | 0.03% |
| Jan. 2, 2026 | Winslow Garrett | General Counsel | S | Common Stock | 255 | $21.38 | 1,854.0000 | 1,327,212 | 12.09% | 0.02% |
| July 3, 2025 | Schambye Hans T. | Chief Executive Officer | M | Common Stock | 1360 | $0.00 | 4,757.0000 | 1,322,359 | 40.04% | 0.10% |
| July 3, 2025 | Schambye Hans T. | Chief Executive Officer | S | Common Stock | 735 | $3.38 | 4,022.0000 | 1,322,359 | 15.45% | 0.06% |
| July 3, 2025 | Firmani Lori | Interim CFO | M | Restricted Stock Units | 374 | $0.00 | 1,100.0000 | 1,322,359 | 25.37% | 0.03% |
| July 3, 2025 | Firmani Lori | Interim CFO | S | Common Stock | 147 | $3.39 | 692.0000 | 1,322,359 | 17.52% | 0.01% |
| July 3, 2025 | Firmani Lori | Interim CFO | M | Common Stock | 374 | $0.00 | 839.0000 | 1,322,359 | 80.43% | 0.03% |
| July 3, 2025 | Winslow Garrett | General Counsel | S | Common Stock | 260 | $3.39 | 1,429.0000 | 1,322,359 | 15.39% | 0.02% |
| July 3, 2025 | Winslow Garrett | General Counsel | M | Common Stock | 680 | $0.00 | 1,689.0000 | 1,322,359 | 67.39% | 0.05% |
| July 3, 2025 | Schambye Hans T. | Chief Executive Officer | M | Restricted Stock Units | 1360 | $0.00 | 4,000.0000 | 1,322,359 | 25.37% | 0.10% |
| July 3, 2025 | Winslow Garrett | General Counsel | M | Restricted Stock Units | 680 | $0.00 | 2,000.0000 | 1,322,359 | 25.37% | 0.05% |
| June 18, 2025 | Shapiro David | Not found | A | Stock Option (right to buy) | 720 | $0.00 | 720.0000 | 1,322,359 | 9999.99% | 0.05% |
| June 18, 2025 | Dallas Jayson Donald Alexander | Not found | A | Stock Option (right to buy) | 720 | $0.00 | 720.0000 | 1,322,359 | 9999.99% | 0.05% |
| June 18, 2025 | WECHSLER AMY B | Not found | A | Stock Option (right to buy) | 720 | $0.00 | 720.0000 | 1,322,359 | 9999.99% | 0.05% |
| June 18, 2025 | GOLDFISCHER CARL | Not found | A | Stock Option (right to buy) | 1440 | $0.00 | 1,440.0000 | 1,322,359 | 9999.99% | 0.11% |
| June 18, 2025 | Prener Anne | Not found | A | Stock Option (right to buy) | 720 | $0.00 | 720.0000 | 1,322,359 | 9999.99% | 0.05% |
| June 18, 2025 | Munshi Amit | Not found | A | Stock Option (right to buy) | 720 | $0.00 | 720.0000 | 1,322,359 | 9999.99% | 0.05% |
| Jan. 3, 2025 | Winslow Garrett | General Counsel | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | Winslow Garrett | General Counsel | M | Common Stock | 1320 | $0.00 | 1,480.0000 | 0 | 825.00% | 0.00% |
| Jan. 3, 2025 | Winslow Garrett | General Counsel | S | Common Stock | 471 | $5.60 | 1,009.0000 | 0 | 31.82% | 0.00% |
| Jan. 3, 2025 | Winslow Garrett | General Counsel | M | Restricted Stock Units | 1320 | $0.00 | 2,680.0000 | 0 | 33.00% | 0.00% |
| Jan. 3, 2025 | Firmani Lori | Interim CFO | M | Common Stock | 726 | $0.00 | 726.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | Firmani Lori | Interim CFO | S | Common Stock | 261 | $5.63 | 465.0000 | 0 | 35.95% | 0.00% |
| Jan. 3, 2025 | Firmani Lori | Interim CFO | M | Restricted Stock Units | 726 | $0.00 | 1,474.0000 | 0 | 33.00% | 0.00% |
| Jan. 3, 2025 | Firmani Lori | Interim CFO | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | Kronmiller Matthew | EVP Strategy and CBO | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2025 | Schambye Hans T. | Chief Executive Officer | M | Common Stock | 2640 | $0.00 | 4,738.0000 | 0 | 125.83% | 0.00% |
| Jan. 3, 2025 | Schambye Hans T. | Chief Executive Officer | S | Common Stock | 1341 | $5.60 | 3,397.0000 | 0 | 28.30% | 0.00% |
| Jan. 3, 2025 | Schambye Hans T. | Chief Executive Officer | M | Restricted Stock Units | 2640 | $0.00 | 5,360.0000 | 0 | 33.00% | 0.00% |
| Jan. 3, 2025 | Schambye Hans T. | Chief Executive Officer | A | Stock Option (right to buy) | 16400 | $0.00 | 16,400.0000 | 0 | 9999.99% | 0.00% |
| Oct. 11, 2024 | WECHSLER AMY B | Not found | A | Stock Option (right to buy) | 480 | $0.00 | 480.0000 | 0 | 9999.99% | 0.00% |
| Oct. 11, 2024 | WECHSLER AMY B | Not found | A | Stock Option (right to buy) | 720 | $0.00 | 720.0000 | 0 | 9999.99% | 0.00% |
| Oct. 9, 2024 | Kronmiller Matthew | EVP Strategy and CBO | A | Stock Option (right to buy) | 8600 | $0.00 | 8,600.0000 | 0 | 9999.99% | 0.00% |
| Oct. 9, 2024 | Schambye Hans T. | Chief Executive Officer | A | Stock Option (right to buy) | 44100 | $0.00 | 44,100.0000 | 0 | 9999.99% | 0.00% |
| Oct. 9, 2024 | Winslow Garrett | General Counsel | A | Stock Option (right to buy) | 15600 | $0.00 | 15,600.0000 | 0 | 9999.99% | 0.00% |
| Oct. 9, 2024 | Firmani Lori | Interim CFO | A | Stock Option (right to buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Munshi Amit | Not found | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Shapiro David | Not found | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Dallas Jayson Donald Alexander | Not found | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Prener Anne | Not found | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | GOLDFISCHER CARL | Not found | A | Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | Winslow Garrett | General Counsel | A | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | Schambye Hans T. | Chief Executive Officer | A | Restricted Stock Units | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | Freve Jonathan | Chief Financial Officer | A | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 15, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 535534 | $0.75 | 1,510,375.0000 | 0 | 26.18% | 0.00% |
| Aug. 15, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 38327 | $0.75 | 97,204.0000 | 0 | 28.28% | 0.00% |
| Aug. 15, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 248819 | $0.75 | 631,048.0000 | 0 | 28.28% | 0.00% |
| July 31, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 26622 | $3.00 | 135,531.0000 | 0 | 16.42% | 0.00% |
| July 31, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 153078 | $3.00 | 2,105,909.0000 | 0 | 6.78% | 0.00% |
| July 31, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 29700 | $3.00 | 879,867.0000 | 0 | 3.27% | 0.00% |
| July 25, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 4700 | $2.92 | 909,567.0000 | 0 | 0.51% | 0.00% |
| July 25, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 7800 | $2.92 | 162,153.0000 | 0 | 4.59% | 0.00% |
| July 25, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 26700 | $2.92 | 2,258,987.0000 | 0 | 1.17% | 0.00% |
| July 13, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 9800 | $2.40 | 169,953.0000 | 0 | 5.45% | 0.00% |
| July 13, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 52800 | $2.40 | 914,267.0000 | 0 | 5.46% | 0.00% |
| July 13, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 132100 | $2.40 | 2,285,687.0000 | 0 | 5.46% | 0.00% |
| June 17, 2023 | Dallas Jayson Donald Alexander | Director | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | GOLDFISCHER CARL | Director | A | Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Munshi Amit | Director | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Khuong Chau Quang | Director | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Shapiro David | Director | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Prener Anne | Director | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| April 13, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 9459 | $1.82 | 2,454,775.0000 | 0 | 0.38% | 0.00% |
| April 13, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 703 | $1.82 | 182,504.0000 | 0 | 0.38% | 0.00% |
| April 13, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 3784 | $1.82 | 981,863.0000 | 0 | 0.38% | 0.00% |
| April 14, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 2091 | $1.86 | 180,413.0000 | 0 | 1.15% | 0.00% |
| April 14, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 11245 | $1.86 | 970,618.0000 | 0 | 1.15% | 0.00% |
| April 14, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 28110 | $1.86 | 2,426,665.0000 | 0 | 1.15% | 0.00% |
| April 17, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 660 | $1.97 | 179,753.0000 | 0 | 0.37% | 0.00% |
| April 17, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 3551 | $1.97 | 967,067.0000 | 0 | 0.37% | 0.00% |
| April 17, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 8878 | $1.97 | 2,417,787.0000 | 0 | 0.37% | 0.00% |
| April 11, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 703 | $1.82 | 183,326.0000 | 0 | 0.38% | 0.00% |
| April 11, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 9459 | $1.82 | 2,465,837.0000 | 0 | 0.38% | 0.00% |
| April 11, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 3784 | $1.82 | 986,288.0000 | 0 | 0.38% | 0.00% |
| April 12, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 1603 | $1.81 | 2,464,234.0000 | 0 | 0.07% | 0.00% |
| April 12, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 641 | $1.81 | 985,647.0000 | 0 | 0.06% | 0.00% |
| April 12, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 119 | $1.81 | 183,207.0000 | 0 | 0.06% | 0.00% |
| April 10, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 2584 | $1.79 | 185,910.0000 | 0 | 1.37% | 0.00% |
| April 10, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 13899 | $1.79 | 1,000,187.0000 | 0 | 1.37% | 0.00% |
| April 10, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 34745 | $1.79 | 2,500,582.0000 | 0 | 1.37% | 0.00% |
| April 5, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 25220 | $2.18 | 1,006,591.0000 | 0 | 2.44% | 0.00% |
| April 6, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 6558 | $2.00 | 2,510,041.0000 | 0 | 0.26% | 0.00% |
| April 6, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 2620 | $2.00 | 1,003,971.0000 | 0 | 0.26% | 0.00% |
| April 6, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 487 | $2.00 | 186,613.0000 | 0 | 0.26% | 0.00% |
| April 5, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 63058 | $2.18 | 2,516,599.0000 | 0 | 2.44% | 0.00% |
| April 5, 2023 | ORBIMED ADVISORS LLC | TenPercentOwner | S | Common Stock | 4687 | $2.18 | 187,100.0000 | 0 | 2.44% | 0.00% |
| Jan. 4, 2023 | Lindmark Bertil | Chief Medical Officer | A | Stock Option (right to buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2023 | Schambye Hans T. | Chief Executive Officer | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2023 | Oestreich Stephanie | Chief Business Officer | A | Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2023 | Pedersen Anders | Chief Operating Officer | A | Stock Option (right to buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2023 | Freve Jonathan | Chief Financial Officer | A | Stock Option (right to buy) | 115000 | $0.00 | 115,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 4, 2023 | Winslow Garrett | General Counsel | A | Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 0 | 9999.99% | 0.00% |